A Phase II Study of Repeat Intranodal Injections of Adenovirus-CD 154 (Ad-ISF35) in Patients With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma
Phase of Trial: Phase II
Latest Information Update: 23 Nov 2015
At a glance
- Drugs CD154 gene therapy (Primary)
- Indications Chronic lymphocytic leukaemia
- Focus Therapeutic Use
- 30 Jul 2015 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov record.
- 08 Apr 2011 Planned end date changed from 1 Dec 2010 to 1 Dec 2011 as reported by ClinicalTrials.gov.
- 29 Sep 2010 Planned end date changed from 1 Jan 2010 to 1 Dec 2010 as reported by ClinicalTrials.gov.